🇺🇸 FDA
Patent

US 9493845

Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same

granted A61PA61P35/00A61P9/10

Quick answer

US patent 9493845 (Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same) held by PTC THERAPEUTICS, INC. expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P35/00, A61P9/10